Bill > HB2965

This bill prohibits manufacturers or repackagers, or their agents, from interfering with the acquisition or delivery of 340B drugs to 340B covered entities, which are healthcare organizations that can purchase outpatient drugs at reduced prices under the federal 340B Drug Pricing Program, or to pharmacies contracted with these entities, unless federal law prohibits such receipt. It also prevents manufacturers from requiring these entities or their contracted pharmacies to share claims or utilization data as a condition for obtaining 340B drugs, unless mandated by the U.S. Department of Health and Human Services. The Arizona State Board of Pharmacy is empowered to investigate violations by licensed individuals or entities and impose disciplinary actions, while the Attorney General can enforce these provisions as unlawful practices, with each instance of prohibited action on a drug package considered a separate violation. The bill clarifies that it does not create a private right of action for violations and must be interpreted in a manner consistent with federal law, specifically noting that limited drug distribution required by federal law or for controlled substances is not a violation.

Health and Social Services

https://apps.azleg.gov/BillStatus/BillOverview/85170